Literature DB >> 24582964

Transformed epithelia trigger non-tissue-autonomous tumor suppressor response by adipocytes via activation of Toll and Eiger/TNF signaling.

Federica Parisi1, Rhoda K Stefanatos1, Karen Strathdee1, Yachuan Yu1, Marcos Vidal2.   

Abstract

High tumor burden is associated with increased levels of circulating inflammatory cytokines that influence the pathophysiology of the tumor and its environment. The cellular and molecular events mediating the organismal response to a growing tumor are poorly understood. Here, we report a bidirectional crosstalk between epithelial tumors and the fat body-a peripheral immune tissue-in Drosophila. Tumors trigger a systemic immune response through activation of Eiger/TNF signaling, which leads to Toll pathway upregulation in adipocytes. Reciprocally, Toll elicits a non-tissue-autonomous program in adipocytes, which drives tumor cell death. Hemocytes play a critical role in this system by producing the ligands Spätzle and Eiger, which are required for Toll activation in the fat body and tumor cell death. Altogether, our results provide a paradigm for a long-range tumor suppression function of adipocytes in Drosophila, which may represent an evolutionarily conserved mechanism in the organismal response to solid tumors.
Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24582964     DOI: 10.1016/j.celrep.2014.01.039

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  39 in total

1.  Tissue-autonomous immune response regulates stress signaling during hypertrophy.

Authors:  Robert Krautz; Dilan Khalili; Ulrich Theopold
Journal:  Elife       Date:  2020-12-30       Impact factor: 8.140

Review 2.  Drosophila as a Genetic Model for Hematopoiesis.

Authors:  Utpal Banerjee; Juliet R Girard; Lauren M Goins; Carrie M Spratford
Journal:  Genetics       Date:  2019-02       Impact factor: 4.562

3.  Temporal specificity and heterogeneity of Drosophila immune cells.

Authors:  Rosy Sakr; Alexia Pavlidaki; Pierre B Cattenoz; Claude Delaporte; Andrea Riba; Nacho Molina; Nivedita Hariharan; Tina Mukherjee; Angela Giangrande
Journal:  EMBO J       Date:  2020-03-12       Impact factor: 11.598

4.  A Drosophila Tumor Suppressor Gene Prevents Tonic TNF Signaling through Receptor N-Glycosylation.

Authors:  Geert de Vreede; Holly A Morrison; Alexandra M Houser; Ryan M Boileau; Ditte Andersen; Julien Colombani; David Bilder
Journal:  Dev Cell       Date:  2018-06-04       Impact factor: 12.270

5.  Extracellular Reactive Oxygen Species Drive Apoptosis-Induced Proliferation via Drosophila Macrophages.

Authors:  Caitlin E Fogarty; Neha Diwanji; Jillian L Lindblad; Meghana Tare; Alla Amcheslavsky; Kalpana Makhijani; Katja Brückner; Yun Fan; Andreas Bergmann
Journal:  Curr Biol       Date:  2016-02-18       Impact factor: 10.834

6.  Spatially Restricted Regulation of Spätzle/Toll Signaling during Cell Competition.

Authors:  Lale Alpar; Cora Bergantiños; Laura A Johnston
Journal:  Dev Cell       Date:  2018-08-23       Impact factor: 12.270

Review 7.  Macrophages and cellular immunity in Drosophila melanogaster.

Authors:  Katrina S Gold; Katja Brückner
Journal:  Semin Immunol       Date:  2016-04-23       Impact factor: 11.130

Review 8.  Tumour-host interactions through the lens of Drosophila.

Authors:  David Bilder; Katy Ong; Tsai-Ching Hsi; Kavya Adiga; Jung Kim
Journal:  Nat Rev Cancer       Date:  2021-08-13       Impact factor: 60.716

9.  Dynamin controls extracellular level of Awd/Nme1 metastasis suppressor protein.

Authors:  Patrizia Romani; Alessio Papi; Marilena Ignesti; Giulia Soccolini; Tien Hsu; Giuseppe Gargiulo; Enzo Spisni; Valeria Cavaliere
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-07-22       Impact factor: 3.000

10.  Intramacrophage ROS Primes the Innate Immune System via JAK/STAT and Toll Activation.

Authors:  Sveta Chakrabarti; Sandhya S Visweswariah
Journal:  Cell Rep       Date:  2020-11-10       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.